548 filings
Page 3 of 28
SC14D9C
ifpp45 kv
1 Nov 22
Written communication relating to third party tender offer
9:27pm
SC TO-C
0njhxe3s9przv
1 Nov 22
Information about tender offer
5:25pm
8-K
wlgf0ao
1 Nov 22
Abiomed Announces Second Quarter Revenue of $266 Million, Up 11% In Constant Currency*, Up 7% on a Reported Basis Year Over Year
8:14am
SC14D9C
2l7 aburlya
1 Nov 22
Written communication relating to third party tender offer
7:40am
8-K
hg5d6ch 17fh1m
1 Nov 22
Johnson & Johnson to Acquire Abiomed
7:39am
8-K
35gtvrmok3ab2i13
12 Aug 22
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
hiw3gk5
4 Aug 22
Results of Operations and Financial Condition
7:14am
DEFA14A
2x2efm7ky4plbyhi9n
28 Jun 22
Additional proxy soliciting materials
4:32pm
8-K
zx4uohe5n6hq
21 Jun 22
Other Events
7:12am
SD
0l12jetf
20 May 22
Conflict minerals disclosure
4:10pm
8-K
81pgtc4 yclwrau
28 Apr 22
Abiomed Announces Fourth Quarter Record Revenue of $270 Million, Up 12% Year Over Year
7:30am
8-K
1sh43nljnh 7e
1 Apr 22
Departure of Directors or Certain Officers
4:30pm
8-K
y1drpj6c
3 Feb 22
Abiomed Announces Record Revenue of $261 Million, Up 13% Year Over Year
7:19am
8-K
m492r
28 Oct 21
Abiomed Announces Q2 Fy 2022 Revenue of $248 Million, Up 18% Year Over Year
7:26am
8-K
pow292n 5q6r29js2c6w
13 Aug 21
Entry into a Material Definitive Agreement
4:01pm